Hester Biosciences Limited (NSE:HESTERBIO)
India · Delayed Price · Currency is INR 1,893.00
+11.10 (0.59%)
May 22, 2026, 3:29 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 15.89 billion as of May 22, 2026. Its market cap has increased by 4.05% in one year.
Market Cap
15.89B
Enterprise Value
17.84B
Revenue
3.33B
Ranking
n/a
PE Ratio
28.55
Stock Price
1,893.00
Market Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 15.89B, an increase of 71,962.36%. That is a compound annual growth rate of 24.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 15.89B | 17.31% |
| Dec 31, 2025 | 13.54B | -33.49% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 48.54B |
| RPG Life Sciences | 37.94B |
| Orchid Pharma | 35.83B |
| Solara Active Pharma Sciences | 26.40B |
| Indoco Remedies | 18.38B |
| Sakar Healthcare | 16.95B |
| Windlas Biotech | 16.67B |
| Jagsonpal Pharmaceuticals | 14.09B |